A critique of the moral economy of pharmaceutical development
Bibliographic Data
| ID | 6420948 |
|---|---|
| Authors | Jonathan Kimmelman (0000-0003-1614-6779, McGill University, corresponding author) |
| Year | 2025 |
| Volume | 19 |
| Issue | 2 |
| Pages | 337-355 |
| Publication date | 2025-01-31 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Critical Policy Studies (JOURNAL) |
| Journal identifiers | ISSN: 1946-0171 • E-ISSN: 1946-018X |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/19460171.2025.2457529 |
| OpenAlex | W4407022977 |
| Language | EN |
| References cited | 53 |
Economic system · Economics · Moral economy · Neoclassical economics · Political science · Politics · Positive economics · Sociology · Biomedical Ethics and Regulation · Law · Pharmaceutical Economics and Policy · Science, Research, and Medicine
International Ethical Guidelines for Health-related Research involving Humans
Development and Preliminary Testing of the Perceived Benefit and Burden Scales for Cancer Clinical Trial Participation
A New Measure of Research Participant Burden
Animal Rights
We are the heroes because we are ready to die for this country
| Citation velocity | historical |
|---|---|
| Highly cited | No |